We agree with other authors that the classification criteria for APS should be revised to include IgA aB2GPI antibodies in patients with SLE [18] but perhaps it is even more important to include these criteria in PAPS. The gene discussed is CD79A; the disease is autoimmune polyendocrinopathy.